American Association for Cancer Research
Browse
00085472can160559-sup-162747_2_supp_3656811_2d3rq3.pdf (810.9 kB)

Figure S1. Pan-BET protein inhibition does not affect cell proliferation or viability from BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling

Download (810.9 kB)
journal contribution
posted on 2023-03-31, 00:29 authored by Guillaume Andrieu, Anna H. Tran, Katherine J. Strissel, Gerald V. Denis

(A) MTT assay showing viability of MDA-MB-231, SUM149PT and MCF-7 cells treated either with 400 nM (R)-JQ1 (filled symbol) or (S)-JQ1 (open symbol) for the indicated times. Dots represent means {plus minus} SEM of three independent experiments. Statistical analysis was performed by using two-way ANOVA. (B) Dot plots of annexin V/propidium iodide co-staining of MDA-MB-231 and SUM149PT cells treated with either 400 nM (R)-JQ1 (upper panels) or (S)-JQ1 (lower panels) for 24h. Quadrant 1 (Q1): necrotic cells, Q2: late apoptotic cells, Q3: early apoptotic cells, Q4: viable cells. The percentage of cells in each quadrant is indicated. At least 20,000 cells were analyzed (n=3). Bottom panel: bars show means {plus minus} SEM of the percentage of annexin V-positive cells (n=3). Statistical analysis was performed by using Student's t test. (C) Cell cycle distribution of MDA-MB-231 and SUM149PT treated with 400 nM (R)-JQ1 (upper panels) or (S)-JQ1 (lower panels) for 24h. The percentage of cells in each phase is indicated. At least 10,000 cells were analyzed (n=3). Bottom panel: bars show means {plus minus} SEM of the percentage of cells in each phase of the cell cycle (n=3). Statistical analysis was performed by using two-way ANOVA.

Funding

NIH

History

ARTICLE ABSTRACT

The bromodomain and extraterminal (BET) proteins are epigenetic “readers” of acetylated histones in chromatin and have been identified as promising therapeutic targets in diverse cancers. However, it remains unclear how individual family members participate in cancer progression and small molecule inhibitors such as JQ1 can target functionally independent BET proteins. Here, we report a signaling pathway involving BRD4 and the ligand/receptor pair Jagged1/Notch1 that sustains triple-negative breast cancer migration and invasion. BRD4, but not BRD2 or BRD3, regulated Jagged1 expression and Notch1 signaling. BRD4-selective knockdown suppressed Notch1 activity and impeded breast cancer migration and invasion. BRD4 was required for IL6-stimulated, Notch1-induced migration and invasion, coupling microenvironment inflammation with cancer propagation. Moreover, in patients, BRD4 and Jagged1 expression positively correlated with the presence of distant metastases. These results identify a BRD4/Jagged1/Notch1 signaling pathway that is critical for dissemination of triple-negative breast cancer. Cancer Res; 76(22); 6555–67. ©2016 AACR.

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC